UPC_APP_16306/2025

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

Procedural & sub-applicationsWithdrawal ApplicationsDusseldorf LDApplication Rop 265—Settled at: Pre-merits

2025-04-11WithdrawnproceduralApplication Rop 265
The Düsseldorf Local Division allowed GlaxoSmithKline Biologicals SA's withdrawal of its infringement action against Pfizer entities concerning EP 4 183 412 with the consent of all defendants, declared the proceedings closed, and ordered reimbursement of 60% of court fees amounting to EUR 201,600.